CARIS LIFE SCIENCES, INC.
CARIS LIFE SCIENCES, INC.
IRVING, TX
Loading...
Price History
Market Data
| Market Cap | 3.14B |
| P/E Ratio | - |
| P/B Ratio | 5.43 |
| EPS | -3.22 |
| Dividend Yield | - |
| D/E Ratio | 0.95 |
| Current Ratio | 7.85 |
| Currency | USD |
Key Financial Metrics
812.03M
Revenue
-68.09M
Net Income
-3.22
EPS (Diluted)
66.89M
Free Cash Flow
Profitability
Gross Margin
32.8%
Operating Margin
5.6%
Net Profit Margin
-8.4%
EBITDA
67.73M
Returns & Efficiency
Return on Assets (ROA)
-6.0%
Return on Equity (ROE)
-11.8%
Dividend Yield
-
EPS
-3.22
Financial Health
Total Assets
1.13B
Total Debt
378.45M
Debt to Equity
0.95x
Current Ratio
7.85
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Health Services |
| HQ | IRVING, TX |
| Fiscal Year | 2025 |
Peers
NATERA, INC.
NTRA
29.64B
P/E: --
21.16B
P/E: --
21.16B
P/E: --
21.14B
P/E: --
11.88B
P/E: --
11.88B
P/E: --
EXACT SCIENCES CORP
EXAS
9.06B
P/E: --
CELCUITY INC.
CELC
6.80B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$3.14B
P/E Ratio (TTM)-
Price to Book5.43
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin32.8%
Operating Margin5.6%
Net Margin-8.4%
ROE-11.8%
ROA-6.0%
Leverage & Liquidity
Debt to Equity0.95
Current Ratio7.85
Total Debt$378.45M
Total Assets$1.13B
Stockholders' Equity$577.31M
Income Statement (FY 2025)
Revenue$812.03M
Gross Profit$266.30M
Operating Income$45.11M
Net Income$-68.09M
EPS (Diluted)$-3.22
Cash Flow (FY 2025)
Free Cash Flow$66.89M
Cash & Equivalents$796.27M
Revenue Growth-
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING, TX 75039 |
| Phone | (866) 771-8946 |
| Incorporated | TX, US |
| EIN | 852077369 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 167.21M |
| Stockholders' Equity | $577.31M |
| Cash & Equivalents | $796.27M |
Recent Filings
View All
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-23
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-23
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-23
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-04-07
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-02
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-26
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-02-13
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-02-05
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-05
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | CARIS LIFE SCIENCES, INC. |
| Ticker | CAI |
| Exchange | -- |
| Sector | Services |
| Industry | Health Services |
| Headquarters | IRVING, TX |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 3.14B |
| Revenue | 812.03M |
| Net Income | -68.09M |
| P/E Ratio | - |
| EPS | -3.22 |
| Net Margin | -8.4% |
| ROE | -11.8% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...